JDRF funds research that can benefit everyone with type 1 diabetes (T1D). We continually strive to improve the lives of people with T1D, until we reach our end goal: a world without T1D.
In just the last financial year, here's what we have achieved together
- $13M invested in T1D research
- 52 studies and clinical trials funded
- 496,560 needles avoided via the insulin pump program
- 17.6 million finger pricks avoided via the CGM Funding Initiative
- 1247 Support and education packs (KIDSACs) delivered to newly diagnosed families
- 2400+ people involved in studies/ trials
- $6.4M raised through the generosity of the T1D community
- 84% of insulin pump recipients reported improvement in HbA1c/Time in Range since starting pump therapy
- People above the age of 23 are now eligible for CGM subsidy
Over the years we have achieved
- $152M invested in T1D research
- 375+ T1D research projects undertaken
- 12.8M fewer needles with the Insulin Pump Program
- 19 countries actively conducting type T1D clinical research, supported by JDRF
- More than 4200 Australian families now avoiding insulin needles thanks to the insulin pump program
- 20 people living insulin free
- $54.5M bi-partisan (2019) promise for clinical research funding
- $134M in Government subsidies
- People <21 years old elgible for CGM subsidy
Read more about our latest research progress or sign up to our newsletter to get it right in your inbox each month.
